You can edit almost every page by Creating an account. Otherwise, see the FAQ.

Gancotamab

From EverybodyWiki Bios & Wiki

Gancotamab
Monoclonal antibody
TypeSingle-chain variable fragment
SourceHuman
TargetERBB2
Clinical data
SynonymsMM-302
ATC code
  • none
Identifiers
CAS Number
UNII
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}
Chemical and physical data
Molar mass25.8 g/mol

Gancotamab (MM-302) (INN) is an antibody fragment designed for the treatment of cancer.[1][2]

This drug is being developed by Merrimack Pharmaceuticals.

References[edit]

  1. Statement On A Nonproprietary Name Adopted By The USAN Council - Gancotamab, American Medical Association.
  2. World Health Organization (2018). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 119" (PDF). WHO Drug Information. 32 (2).


This article "Gancotamab" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Gancotamab. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.